WSSAAI 2022 Northwest Allergy Forum
The Northwest Allergy Forum is a CME educational meeting jointly provided by the American College of Allergy, Asthma & Immunology and the Oregon and Washington Societies of Allergy, Asthma & Immunology. The program is a two-day event with speakers covering a range of topics such as asthma, eczema, food allergy, vocal cord dysfunction and research developments.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and Washington State Society of Allergy, Asthma & Immunology (WSSAAI). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.”
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 8 contact hours.
Commercial Support
This activity is supported in part by independent medical education grants from Biocryst and CSL Behring.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
Upon completion of this activity the participant should be able to:
1. Identify the most effective medical treatments for CRS
2. Assess the benefits and limitations of the available treatments for HAE
3. Use clinical, laboratory, and genetic features to formulate a treatment regimen for CVID that addresses both immune deficiency and immune dysregulation features of the disease.
4. Identify advantages and disadvantages of all methods of food allergy treatment
Northwest Allergy Forum
October 8-9, 2022
Grand Hyatt
721 Pine Street
Seattle, WA
Saturday, October 8th
6:45am-7:45am Non-CME Sponsored Breakfast Program – Discovery A
6:30am-7:50am Exhibits | Registration | Coffee Break – Princessa
NWAF General Session – Eliza Anderson Amphitheater
7:50am-8:00am Welcome & Introduction – Mark LaShell, MD – President, WSSAAI
Session Moderator – Mark Tucker, MD – Program Chair, WSSAAI
8:00am-9:00am Allergic Contact Dermatitis, Kevin Cook, MD
9:00am-10:00am Diagnosis and Management of Autoimmune Complications in Patients with Immune Deficiency, Troy Torgerson, MD, PhD
10:00am-10:30am Coffee Break | Exhibits – Princessa
10:30-11:30am Microbiome and Eczema, Ian Myles, MD, MPH
11:30am-12:30pm Autoinflammatory Syndromes, Lori Broderick, MD, PhD
12:30pm Adjourn
12:30-1:30pm WSSAAI State Society Luncheon – Discovery B
OSAAI State Society Luncheon – Discovery A
4:00pm-5:00pm Non-CME Sponsored Program/Reception
Sunday, October 9th
6:45am-7:45am Non-CME Sponsored Breakfast Program – Discovery A
7:00am-7:50am Exhibits | Coffee Break – Princessa
NWAF General Session – Eliza Anderson Amphitheater
7:50am-8:00am Welcome & Introduction
Session Moderator– Daniel Petroni, MD, PhD – Associate Program Chair, WSSAAI
8:00am-9:00am Food Allergy Update: Prevention, Oral Challenges, and Immunotherapy, Stephanie Leonard, MD
9:00am-10:00am Advances in FPIES: Diagnosis, Emergency Care, and Long-Term Management, Stephanie Leonard, MD
10:00am-10:30am Coffee Break | Exhibits – Princessa
10:30am-11:30am Hereditary Angioedema – An Update on Diagnosis and Management, Marc Riedl, MD, MS
11:30am-12:30pm Chronic Rhinosinusitis and Use of Biologics, Ian M. Humphreys, DO, FARS
12:30pm Adjourn
All identified relevant financial relationships have been mitigated.
Lori Broderick, MD
Researcher: Novartis
Kevin Cook, MD
Advisor: ALK, Sanofi
Stephanie Leonard, MD
Speaker: Aimmune Therapeutics
Advisor: Aimmune Therapeutics, DBV Technologies, Cour Pharmaceuticals Development Co., Inc.
Marc Riedl, MD, MS
Consultant: Astria, BioCryst, Biomarin, CSL Behring, Cycle Pharma, Fresenius-Kabi, Ipsen, KalVista, Pfizer, Pharming, Pharvaris, RegenexBio, Sanofi-Regeneron, Takeda
Research Support: BioCryst, Biomarin, CSL Behring, Ionis, KalVista, Pharvaris, Takeda
Speaker: CSL Behring, Grifols, Pharming, Takeda
Troy Torgerson, MD, PhD
Advisor: Pharming Healthcare, Takeda
Consultant: Horizon Therapeutics, Takeda
Dan Petroni, MD
Consultant: Jubilant Hollister-Stier, Takeda
Speaker: AstraZeneca
Ted Song, DO
Consultant: Genentech
Speaker: AstraZeneca, Boehringer -Ingelheim
The following have no relevant financial relationships to disclose:
Ian M. Humphreys, DO, FARS
Ian A. Myles, MD, MPH
Mark LaShell, MD
Mark Tucker, MD
Mary Lasley, MD
Karol Anderson
Available Credit
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Attendance
- 8.00 CBRN